Recognition of the nonclassical MHC class i molecule H2-M3 by the receptor Ly49A regulates the licensing and activation of NK cells

Nature Immunology

Volumn 13, Issue 12, 2012, Pages 1171-1177

  Andrews, Daniel M ^a,b   Sullivan, Lucy C ^b   Baschuk, Nikola ^a,b   Chan, Christopher J ^a,c   Berry, Richard ^d   Cotterell, Claire L ^a,b   Lin, Jie ^b   Halse, Heloise ^a,b   Watt, Sally V ^a,b   Poursine Laurent, Jennifer ^e   Wang, Chyung Ru ^f   Scalzo, Anthony A ^g,h   Yokoyama, Wayne M ^e   Rossjohn, Jamie ^d   Brooks, Andrew G ^b   Smyth, Mark J ^a,b,c  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d MONASH UNIVERSITY   (Australia)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

^g UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^h LIONS EYE INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN; MAJOR HISTOCOMPATIBILITY COMPLEX CLASS 1 MOLECULE H2 M3; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY A; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE MARROW; CARCINOGENESIS; METASTASIS; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; HISTOCOMPATIBILITY ANTIGENS CLASS I; IMMUNE TOLERANCE; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY A;

EID: 84869410235     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.2468     Document Type: Article

References (50)

1. Chan, C.J. et al. Can NK cells be a therapeutic target in human cancer? Eur. J. Immunol. 38, 2964-2968 (2008).
2. Ljunggren, H.G. & Malmberg, K.J. Prospects for the use of NK cells in immunotherapy of human cancer. Nat. Rev. Immunol. 7, 329-339 (2007).
3. Andoniou, C.E. et al. Natural killer cells in viral infection: more than just killers. Immunol. Rev. 214, 239-250 (2006). (Pubitemid 44707915)
4. Karlhofer, F.M. et al. MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells. Nature 358, 66-70 (1992).
5. Yu, Y.Y. et al. The role of Ly49A and 5E6(Ly49C) molecules in hybrid resistance mediated by murine natural killer cells against normal T cell blasts. Immunity 4, 67-76 (1996). (Pubitemid 26054937)
6. Kärre, K. et al. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 319, 675-678 (1986). (Pubitemid 16119452)
7. Kärre, K. How to recognize a foreign submarine. Immunol. Rev. 155, 5-9 (1997). (Pubitemid 27076054)
8. Natarajan, K. et al. Interaction of the NK cell inhibitory receptor Ly49A with H-2Dd: identification of a site distinct from the TCR site. Immunity 11, 591-601 (1999).
9. Held, W. et al. Major histocompatibility complex class I-dependent skewing of the natural killer cell Ly49 receptor repertoire. Eur. J. Immunol. 26, 2286-2292 (1996). (Pubitemid 26340925)
10. Valiante, N.M. et al. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 7, 739-751 (1997). (Pubitemid 28064888)
11. Hanke, T. et al. Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors. Immunity 11, 67-77 (1999). (Pubitemid 29359958)
12. Fernandez, N.C. et al. A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood 105, 4416-4423 (2005). (Pubitemid 40720789)
13. Höglund, P. et al. Recognition of β2-microglobulin-negative (β2m?) T-cell blasts by natural killer cells from normal but not from β2m? mice: nonresponsiveness controlled by β2m? bone marrow in chimeric mice. Proc. Natl. Acad. Sci. USA 88, 10332-10336 (1991). (Pubitemid 21915829)
14. Raulet, D.H. & Vance, R.E. Self-tolerance of natural killer cells. Nat. Rev. Immunol. 6, 520-531 (2006). (Pubitemid 43980524)
15. Kim, S. et al. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 436, 709-713 (2005). (Pubitemid 41117274)
16. Kumar, V. & McNerney, M.E. A new self: MHC-class-I-independent natural-killer-cell self-tolerance. Nat. Rev. Immunol. 5, 363-374 (2005). (Pubitemid 40685986)
17. Vance, R.E. et al. Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1b. J. Exp. Med. 188, 1841-1848 (1998). (Pubitemid 28536771)
18. Hanke, T. et al. Identification of an immunodominant cytotoxic T-lymphocyte recognition site in glycoprotein B of herpes simplex virus by using recombinant adenovirus vectors and synthetic peptides. J. Virol. 65, 1177-1186 (1991).
19. Borrego, F. et al. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J. Exp. Med. 187, 813-818 (1998). (Pubitemid 28115198)
20. Braud, V.M. et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 391, 795-799 (1998). (Pubitemid 28099678)
21. Ohtsuka, M. et al. Major histocompatibility complex (MHC) class Ib gene duplications, organization and expression patterns in mouse strain C57BL/6. BMC Genomics 9, 178 (2008).
22. Chiu, N.M. et al. The majority of H2-M3 is retained intracellularly in a peptide-receptive state and traffics to the cell surface in the presence of N-formylated peptides. J. Exp. Med. 190, 423-434 (1999). (Pubitemid 29374839)
23. Loveland, B. et al. Maternally transmitted histocompatibility antigen of mice: a hydrophobic peptide of a mitochondrially encoded protein. Cell 60, 971-980 (1990).
24. Gulden, P.H. et al. A Listeria monocytogenes pentapeptide is presented to cytolytic T lymphocytes by the H2-M3 MHC class Ib molecule. Immunity 5, 73-79 (1996). (Pubitemid 26254786)
25. Lenz, L.L. et al. Identification of an H2-M3-restricted Listeria epitope: implications for antigen presentation by M3. Immunity 5, 63-72 (1996). (Pubitemid 26254785)
26. Wang, C.R. et al. H-2M3 encodes the MHC class I molecule presenting the maternally transmitted antigen of the mouse. Cell 66, 335-345 (1991).
27. Colmone, A. & Wang, C.-R. H2-M3-restricted T cell response to infection. Microbes Infect. 8, 2277-2283 (2006). (Pubitemid 44311604)
28. Xu, H. et al. Impaired response to Listeria in H2-M3-deficient mice reveals a nonredundant role of MHC class Ib-specific T cells in host defense. J. Exp. Med. 203, 449-459 (2006). (Pubitemid 43290853)
29. Deng, L. et al. Molecular architecture of the major histocompatibility complex class I-binding site of Ly49 natural killer cell receptors. J. Biol. Chem. 283, 16840-16849 (2008).
30. Brennan, J. et al. Recognition of class I major histocompatibility complex molecules by Ly-49: specificities and domain interactions. J. Exp. Med. 183, 1553-1559 (1996).
31. Brodin, P. et al. The strength of inhibitory input during education quantitatively tunes the functional responsiveness of individual natural killer cells. Blood 113, 2434-2441 (2009).
32. Johansson, S. et al. Probing natural killer cell education by Ly49 receptor expression analysis and computational modelling in single MHC class I mice. PLoS ONE 4, e6046 (2009).
33. Michaëlsson, J. et al. Visualization of inhibitory Ly49 receptor specificity with soluble major histocompatibility complex class I tetramers. Eur. J. Immunol. 30, 300-307 (2000). (Pubitemid 30011792)
34. Scarpellino, L. et al. Interactions of Ly49 family receptors with MHC class I ligands in trans and cis. J. Immunol. 178, 1277-1284 (2007). (Pubitemid 46154597)
35. Burrows, S.R. et al. Peptide-MHC class I tetrameric complexes display exquisite ligand specificity. J. Immunol. 165, 6229-6234 (2000).
36. Wang, J. et al. Binding of the natural killer cell inhibitory receptor Ly49A to its major histocompatibility complex class I ligand. Crucial contacts include both H-2Dd AND β2-microglobulin. J. Biol. Chem. 277, 1433-1442 (2002). (Pubitemid 34968898)
37. Zafirova, B. et al. Altered NK cell development and enhanced NK cell-mediated resistance to mouse cytomegalovirus in NKG2D-deficient mice. Immunity 31, 270-282 (2009).
38. Hayakawa, Y. & Smyth, M.J. CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity. J. Immunol. 176, 1517-1524 (2006). (Pubitemid 43134295)
39. Guerra, N. et al. NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy. Immunity 28, 571-580 (2008).
40. Joncker, N.T. et al. Mature natural killer cells reset their responsiveness when exposed to an altered MHC environment. J. Exp. Med. 207, 2065-2072 (2010).
41. Sun, K. et al. Mouse NK cell-mediated rejection of bone marrow allografts exhibits patterns consistent with Ly49 subset licensing. Blood 119, 1590-1598 (2012).
42. Oberg, L. et al. Loss or mismatch of MHC class I is sufficient to trigger NK cell-mediated rejection of resting lymphocytes in vivo: role of KARAP/DAP12-dependent and-independent pathways. Eur. J. Immunol. 34, 1646-1653 (2004). (Pubitemid 39256046)
43. Chan, P.Y. & Takei, F. Expression of a T cell receptor-like molecule on normal and malignant murine T cells detected by rat monoclonal antibodies to nonclonotypic determinants. J. Immunol. 136, 1346-1353 (1986). (Pubitemid 16156239)
44. Nagasawa, R. et al. Identification of a novel T cell surface disulfide-bonded dimer distinct from the α/β antigen receptor. J. Immunol. 138, 815-824 (1987). (Pubitemid 17012398)
45. Wong, S. et al. Ly-49 multigene family. New members of a superfamily of type II membrane proteins with lectin-like domains. J. Immunol. 147, 1417-1423 (1991).
46. Jonsson, A.H. et al. Effects of MHC class I alleles on licensing of Ly49A+ NK cells. J. Immunol. 184, 3424-3432 (2010).
47. Brodin, P. et al. Skewing of the NK cell repertoire by MHC class I via quantitatively controlled enrichment and contraction of specific Ly49 subsets. J. Immunol. 188, 2218-2226 (2012).
48. Elliott, J.M. & Yokoyama, W.M. Unifying concepts of MHC-dependent natural killer cell education. Trends Immunol. 32, 364-372 (2011).
49. Hoare, H.L. et al. Structural basis for a major histocompatibility complex class Ib-restricted T cell response. Nat. Immunol. 7, 256-264 (2006).
50. Pellicci, D.G. et al. Differential recognition of CD1d-α-galactosyl ceramide by the Vβ8.2 and Vβ7 semi-invariant NKT T cell receptors. Immunity 31, 47-59 (2009).